Siemens Healthineers AG

Siemens Healthineers AG

SEMHF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$52.09B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Siemens Healthineers AGSiemens Healthineers AG22.22.28%11%2.2-

Earnings Call Q4 2026

November 5, 2026 - AI Summary

Q4 + FY26 performance strong; group guidance confidence - Synergetic core delivered +8.1% YoY growth in Q4 (vs. strong comps) and +6.1% for FY26, supported by healthy demand across geographies (Americas +7%, Asia/Pacific Japan double-digit growth, EMEA +4%; China overall -2% with structural market rebasing). - Equipment book-to-bill remained strong: 1.15 in Q4 and 1.14 for FY26 (supports future demand visibility). - Diagnostics: stabilized sequentially, but -4.2% YoY revenue in Q4; sequential margin improved aided by tariff refunds and one-offs. - FY26 earnings: Adj. EPS €2.42, slightly above prior year and within the upper half of outlook; “clean” underlying EPS ~€2.30 (midpoint of €2.20–€2.40 guidance) after stripping tariff refunds and certain Q4 one-offs.
Diagnostics milestone (surprising/positive): Quest extension - Siemens Healthineers extended its long-standing relationship with Quest Diagnostics by 5 years—a direct validation of Atellica platform, assay portfolio, and automation for Core Lab industrialization. - This is positioned as an “exclamation mark” for Atellica relevance and contract durability; Quest is described as a major consolidator/customer in the U.S.
Dividend + shareholder returns (good and clear) - Dividend proposed: €1 per share, aligned with policy of stable-to-progressive payout (management referenced ~50% payout of net income).

Exclusive for Stockcircle Pro members

Sign upSign Up
$20.40

Current Fair Value

56.5% downside

Overvalued by 56.5% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$52.09 Billion
Enterprise Value$50.07 Billion
Annual dividend$1.19
Dividend yield2.28%
Earnings per Share$1.98
Beta0.83
Outstanding Shares1,111,320,755

Return

Return on Equity11.17%ROE
Return on Assets4.75%
Return on Invested Capital9.80%

Valuation & Multiples

P/E Ratio22.2P/E Ratio
PEG5527.05PEG
Price to Sales2.23Price to Sales
Price to Book Ratio2.76Price to Book Ratio
Enterprise Value to Revenue2.12
Enterprise Value to EBIT15.26
Enterprise Value to Net Income22
Total Debt to Enterprise0.01
Debt to Equity0.03Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 5, 2026
EPS
$0.78
Est. $0.76
Revenue
$7.69 B
Est. $7.69 B

Next Earnings Call

Expected Date
February 4, 2027
EPS Estimate
$0.55
Consensus analyst estimate
Revenue Estimate
$6.42 B
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Siemens Healthineers AG

74,000 employees
CEO: Bernhard Montag

Siemens Healthineers AG, operating through its various subsidiaries, is dedicated to the development, production, and worldwide distribution of a comprehensive portfolio of diagnostic and therapeutic solutions for healthcare professional...